You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Cholestyramine - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for cholestyramine and what is the scope of freedom to operate?

Cholestyramine is the generic ingredient in eight branded drugs marketed by Parke Davis, Ajanta Pharma Ltd, Alkem Labs Ltd, Ani Pharms, Endo Operations, Epic Pharma Llc, Ivax Sub Teva Pharms, Tagi, Teva, Upsher Smith Labs, Zydus Pharms, Teva Pharms, Chartwell Rx, Bristol Myers, and Apothecon, and is included in twenty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for cholestyramine. Fourteen suppliers are listed for this compound.

Summary for cholestyramine
Drug Prices for cholestyramine

See drug prices for cholestyramine

Recent Clinical Trials for cholestyramine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Centre Hospitalier Universitaire de NiceN/A
Eli Lilly and CompanyPhase 1
Loxo Oncology, Inc.Phase 1

See all cholestyramine clinical trials

Pharmacology for cholestyramine
Drug ClassBile Acid Sequestrant
Mechanism of ActionBile-acid Binding Activity

US Patents and Regulatory Information for cholestyramine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms CHOLESTYRAMINE cholestyramine POWDER;ORAL 074771-002 Jul 9, 1997 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Tagi CHOLESTYRAMINE cholestyramine POWDER;ORAL 209597-002 Mar 9, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 074555-002 Sep 30, 1998 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx LOCHOLEST LIGHT cholestyramine POWDER;ORAL 074562-001 Aug 15, 1996 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alkem Labs Ltd CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 211799-002 Oct 19, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.